Alissa K. Lipton

Partner

+1 617 646 1643 +1 617 646 1643
alissa.lipton@finnegan.com alissa.lipton@finnegan.com

Two Seaport Lane
Boston, MA 02210-2001

vCard

Show Alissa's work in

Alissa Lipton focuses on trials and appeals and pre-litigation counseling involving a wide range of technologies, including biotechnology, pharmaceutical, and medical device patents. She has particular experience in litigation arising under the Hatch-Waxman Act and litigation relating to biologics.

Alissa is a registered patent attorney and has experience in matters before the U.S. Patent and Trademark Office (USPTO) as well as counseling and opinion work. She has been involved in cases in which the patents-at-issue were subject to co-pending proceedings before the USPTO.

Alissa was recognized as a Boston, Massachusetts, "Rising Star" by The National Law Journal and as an "Up and Coming Attorney" for Excellence in the Law by Massachusetts Lawyers Weekly. She frequently writes and presents on patent law topics relevant to the pharmaceutical and life sciences industries. Alissa is co-author of Court of Appeals for the Federal Circuit: Practice and Procedure. She is also a contributing author of Patent Litigation Strategies Handbook, published by the American Bar Association Section of Intellectual Property Law and Bloomberg BNA.

While in law school, Alissa was a member of the Harvard Journal of Law and Technology.

Et Cetera

Clerkship, U.S. Court of Appeals for the Federal Circuit, Honorable Alvin A. Schall, 2004-2005.
Capital Pro Bono Honor Roll, 2018.

Experience

Represented Health Diagnostic Laboratories in litigation in a suit brought by an exclusive licensee relating to SLCO1B1 genetic tests for statin-induced myopathy.

1:13-cv-13111, D. Mass., Judges Bowler, Saylor, Talwani

Representing Eli Lilly and Company in Hatch-Waxman patent litigation relating to osteoporosis drug Forteo®.

1:16-cv-00596, S.D. Ind., Judges Pratt, Brookman

Represented Duchesnay in Hatch-Waxman litigation, defending against generic attack on Duchesnay's Diclegis® product.

1:14-cv-00912, D. Del., Judges Robinson, Fallon

Assisted ConforMIS in obtaining a successful settlement in a case relating to customizable knee implants.

1:12-cv-01109, D. Del., Judge Sleet

Defended MedImmune, LLC in patent infringement litigation brought by Novartis Vaccines and Diagnostics, Inc. concerning recombinant DNA expression vectors; case ultimately resolved through confidential settlement.

1:11-cv-00084, D. Del., Judges Robinson, Thynge

Represented Eli Lilly in district court and Federal Circuit in ANDA case on patent covering Strattera®, a treatment for ADHD. Prevailed on appeal at the Federal Circuit and patent held to be not invalid and infringed.

10-1500, -1520, -1521, -1522, -1523, -1524, Fed. Cir., Judges Lourie, Newman
2:07-cv-03770, D.N.J., Judges Cavanaugh, Dickson, Falk

2 more

Insights

Workshop

Life Sciences Workshop: Updates and Recent Trends in Pharmaceutical and Biotechnology Patent Law

May 2, 2019

Cambridge

Conference

Bio IP Counsels Committee Conference

November 14-16, 2018

Indianapolis

Webinar

Standing to Appeal to the Federal Circuit from USPTO Proceedings

November 1, 2018

Webinar

Podcasts

Linda Wadler and Alissa Lipton on WesternGeco v. Ion Geophysical

September 2018

Conference

American Chemical Society National Meeting: Nanoscience, Nanotechnology, and Beyond

August 19-23, 2018

Boston

IP FDA Blog

FDA Final Guidance on Labeling for Biosimilar Products

July 23, 2018

21 more

Professional Recognition

"Patent litigator Alissa K. Lipton is known for her exceptional legal writing and advocacy as well as for her pro bono work with veterans appealing disability denials. She has co-authored two widely-used publications, including a practice and procedure treatise for the U.S. Court of Appeals for the Federal Circuit.”